The buccal drug delivery system is a therapeutic option that delivers drugs through buccal mucosal lines (space between the inner cheek and upper gingivae). Through the buccal drug delivery system, the desired therapeutic dose of the drug gets immediately absorbed into plasma, and the consistency of the concentration can be maintained throughout the treatment. The buccal dosage form may be of matrix type or reservoir type. In matrix type, the buccal path is configured in a matrix, comprising drugs, adhesives, and additives. However, in reservoir type, the buccal path is fabricated in a reservoir system, consisting of a cavity for drugs and adhesives separated from the drug.
MARKET DYNAMICS
The buccal drug delivery system market is driving due to the technological advancement and rise in mergers and acquisitions. Moreover, presence of major players in the market and availability of drugs is likely to boost the growth of the global buccal drug delivery system market during the forecast period.
MARKET SCOPE
The "Buccal Drug Delivery System Market Analysis to 2028" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of buccal drug delivery system market with detailed market segmentation by formulation and end user. The buccal drug delivery system market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in buccal drug delivery system market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The buccal drug delivery system market is segmented on the basis of formulation and end user. Based on formulation, the market is segmented as sublingual films, tablets, and sprays. On the basis of end user, the market is categorized as hospitals, clinics, and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the buccal drug delivery system market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The buccal drug delivery system market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting buccal drug delivery system market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the buccal drug delivery system market in these regions.
MARKET PLAYERS
The report covers key developments in the buccal drug delivery system market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from buccal drug delivery system market are anticipated to have lucrative growth opportunities in the future with the rising demand for buccal drug delivery system in the global market. Below mentioned is the list of few companies engaged in the buccal drug delivery system market.
The report also includes the profiles of key players in buccal drug delivery system market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Actavis
- Applied Pharma Research
- Ardea Biosciences
- BioDelivery Sciences
- Cynapsus
- Endo Pharmaceutical
- Ethypharm, Cynapsus
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.